Breaking News, Financial News

Financial Report: Omnicare 3Q

CRO business revenues were $36.9 million in the quarter (-28%).

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Omnicare 3Q09 3Q Revenues: $1.5 billion (-6%) 3Q Earnings: $72.5 million (+35%) YTD Revenues: $4.6 billion (flat) YTD Earnings: $132.1 million (+17%) Comments: CRO business revenues were $36.9 million in the quarter (-28%). Backlog at September 30, 2009 was $235.7 million. The Pharmacy services business generated sales of $1.5 million in the quarter (-1%). Results in 3Q08 include the impact of special items and an accounting change totaling $28.8 million....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters